1 option
Statins : the HMG-CoA reductase inhibitors in perspective / edited by Allan Gaw, Christopher J. Packard, James Shepherd.
Holman Biotech Commons RC632.H87 S728 2004
Available
- Format:
- Book
- Language:
- English
- Subjects (All):
- Hyperlipidemia.
- Antilipemic agents.
- Hypolipidemic Agents.
- Hyperlipidemias.
- Hydroxymethylglutaryl-CoA Reductase Inhibitors.
- Medical Subjects:
- Hypolipidemic Agents.
- Hyperlipidemias.
- Hydroxymethylglutaryl-CoA Reductase Inhibitors.
- Physical Description:
- 262 pages : illustrations ; 26 cm
- Edition:
- Second edition.
- Place of Publication:
- London : Martin Dunitz ; Independence, KY : Distributed in the USA by Fulfilment Center, Taylor & Francis, 2004.
- Summary:
- What is a statin? It is the most powerful lipid-lowering agent yet produced. Its main action is to lower the low-density lipoprotein (LDL) cholesterol level, thereby reducing the overall cholesterol level in the blood. In this new edition of this popular book, the authors examine the existing and emerging statins and their beneficial effectiveness in reducing serum cholesterol. New chapters cover combination therapy in lipid-lowering, new 'Megatrials' (HPS and PPP) and the PROSPER study. Also presented are the effects of statins on non-vascular conditions such as osteoporosis, cancer, dementia and diabetes.
- Notes:
- Includes bibliographical references and index.
- ISBN:
- 1841842923 :
- OCLC:
- 53242500
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.